Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1341 |
|---|---|
| Identifier | NCT05177835 |
| Trial Title | Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: ABX464 |
Participant Information
| Sponsor | Abivax S.A. |
|---|---|
| City | Innsbruck |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2021-12-03 |
|---|---|
| Primary Completion Date | 2026-03 |
| Completion Date | 2026-04 |